1. Home
  2. ASMB vs EU Comparison

ASMB vs EU Comparison

Compare ASMB & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$26.22

Market Cap

414.7M

Sector

Health Care

ML Signal

HOLD

Logo enCore Energy Corp.

EU

enCore Energy Corp.

HOLD

Current Price

$2.66

Market Cap

464.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
EU
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Metals and Minerals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
414.7M
464.5M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
EU
Price
$26.22
$2.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$43.40
$4.00
AVG Volume (30 Days)
98.7K
3.5M
Earning Date
03-19-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,191,000.00
$44,142,000.00
Revenue This Year
$33.33
$17.41
Revenue Next Year
N/A
$95.45
P/E Ratio
N/A
N/A
Revenue Growth
31.30
N/A
52 Week Low
$7.75
$1.01
52 Week High
$39.71
$4.19

Technical Indicators

Market Signals
Indicator
ASMB
EU
Relative Strength Index (RSI) 43.34 41.65
Support Level $25.47 $2.60
Resistance Level $27.50 $2.90
Average True Range (ATR) 1.75 0.24
MACD 0.23 -0.07
Stochastic Oscillator 35.04 4.17

Price Performance

Historical Comparison
ASMB
EU

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About EU enCore Energy Corp.

enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.

Share on Social Networks: